HELE vs HON: Which Is the Better Buy in 2026?
Last updated November 2026
Short answer
HON is the larger of the two ($68.85B market cap): the incumbent the market prices for continued execution (21.97x forward earnings, beta 0.88). HELE is the smaller challenger ($804.87M), cheaper on forward earnings (8.51x): more room to run, but more to prove. If you believe HON earns its premium (21.97x forward earnings, so the market expects more from it), HON fits. If you believe in paying less for profit, HELE fits at 8.51x.
HELE vs HON: the tie-breaker metrics
Same yardstick, side by side (as of November 2026). Valuation lined up like this is most meaningful for two names in the same corner of the market, which these are. Figures are approximate; verify before investing.
| Metric | HELE | HON | What it tells you |
|---|---|---|---|
| Market cap | $804.87M | $68.85B | Size. The larger name is the incumbent; the smaller has more room to grow and more to prove. |
| Forward P/E | 8.51 | 21.97 | Valuation on next year's expected earnings, the same yardstick for both. Lower is cheaper for that growth; higher means the market is paying up. |
| Beta | 1.37 | 0.88 | Volatility vs the market. Above 1 swings harder than the index; below 1 is steadier. Higher beta means bigger drawdowns to hold through. |
| Price vs 52-week range | 82% of range | 32% of range | Where today's price sits between the 52-week low and high. Near the high is momentum with less margin of safety; near the low is out of favor or a discount, depending on why. |
| Price / book | 0.94 | 3.07 | How much you pay over book value. Very high can signal an asset-light, high-return business or a rich price. |
Reading it: HELE is the cheaper of the two on forward earnings, but cheaper is not the same as better. Pair the valuation with growth (how far the forward P/E sits below the trailing P/E) and risk (beta) before you decide.
Before you buy: how HELE and HON affect your concentration
The metrics above tell you which is the marginally better business. The bigger risk for most people is not picking the slightly worse stock, it is over-concentrating. HELE and HON share themes, so owning both, or adding either to what you already hold, can quietly push a large share of your portfolio into one bet.
This is the part a generic comparison page cannot answer, because it depends on what you own. Connect your brokerage and Walnut shows your real, combined HELE and HON exposure, flags overlap with your existing positions, and tells you if adding one would tip you past a concentration you are comfortable with, read-only by default, with your login staying at your broker. Walnut is not an investment adviser.
What does Helen of Troy Limited (HELE) do?
Helen of Troy Limited designs, markets and distributes consumer products across two segments: Home & Outdoor (OXO kitchen and storage tools, Hydro Flask hydration bottles, Osprey packs, PUR filtration) and Beauty & Wellness (Braun and Vicks health devices, Honeywell air treatment, Hot Tools and Drybar hair appliances, Curlsmith). The company sells through mass retail, specialty, and online channels, and manages a portfolio it calls its Leadership Brands while periodically acquiring and divesting smaller labels. Trailing revenue is roughly $1.83 billion (as of November 2026), and the business generates meaningful free cash flow (~$112 million over the trailing twelve months) even as top-line sales have been roughly flat to down.
What does Honeywell International (HON) do?
Honeywell, which now operates as Honeywell Technologies (Nasdaq: HON), describes itself as a global, pure-play automation company serving the building, industrial and process sectors through services, solutions and products, run on its Accelerator operating system and its Forge intelligence layer. It has more than 50,000 employees and decades of operating data from a global installed base. Its Building Automation business sells controls, sensors, fire and security systems for commercial buildings. Industrial Automation covers process control, sensing, warehouse automation and the productivity (barcode scanning) business, and the process-technology franchise licenses refining and petrochemical technology and supplies the equipment and services around it, such as its planned role at the Dangote refinery project in Kenya. Honeywell makes money from a mix of equipment sales, long-cycle projects, recurring service and growing software offerings.
HELE vs HON: how do they differ?
Both fit overlapping themes, but they are not interchangeable. Here is what each one depends on.
- HELE drivers: Leadership Brand portfolio; Cost restructuring and cash flow.
- HON drivers: Pure-play automation focus; Software and physical AI on the installed base.
Which fits which kind of investor
A faster-growing, richer-valued name usually swings harder, so it suits a longer horizon and a higher tolerance for volatility; a steadier, more cash-generative business suits a more conservative or income-minded investor. A useful test is which set of risks you could hold through a drawdown: Revenue growth is minimal (~2% year over year in the latest quarter) and Beauty & Wellness sales are still declining, so a sustained rebound is not guaranteed given consumer discretionary softness and competitive private-label pressure. For HON, as a standalone automation company, Honeywell is more exposed to construction activity, manufacturing capex and energy-sector spending than when aerospace aftermarket revenue cushioned results.
HELE or HON: which should you pick?
If the story you believe is HELE's (Leadership Brand portfolio), HELE is the more direct way to own it; if it is HON's (Pure-play automation focus), HON is. Many investors hold both, but since they share themes, that is a concentrated bet, not diversification. Decide deliberately and check overlap. For the full detail, see the HELE and HON guides.
HELE vs HON: the full fundamentals
HELE. HELE trades at roughly 0.4 times sales and about 8.5 times forward earnings (as of November 2026), a low multiple that reflects flat revenue and a leveraged balance sheet even after the shares rose ~67% this year. Trailing GAAP earnings remain negative because of the ~$886 million fiscal 2026 goodwill and intangibles writedown, so forward adjusted EPS, free cash flow and the pace of debt reduction are the more useful gauges, and some of the fiscal 2027 lift comes from one-time tariff refunds. The rejected $37 cash proposal now gives the market a second reference point: the stock sits about 7% below it.
HON. Honeywell's headline numbers are still hard to read because the June 2026 aerospace spin-off and a large Q2 gain sit inside the trailing figures, which is why the trailing P/E shows near 11x. On forward estimates the stock trades around 22x 2027 EPS of about $9.88 and roughly 8.9x EV/EBITDA, a multiple in line with quality automation peers. The Q3 report gave the first clean standalone quarter, with a modest EPS beat and revenue in line.
Headline figures (approximate, November 2026): HELE shows revenue (ttm) ~$1.83 billion, q2 fy2027 net sales ~$441 million (+2.1% YoY), q2 fy2027 adjusted eps $0.79 vs ~$0.50 estimate, gross margin (ttm) ~45.8%; HON shows revenue (ttm, includes aerospace until june) ~$37.7 billion, q3 2026 revenue (continuing operations) ~$5.0 billion, up ~1.3% YoY, q3 2026 eps ~$2.27 vs ~$2.16 estimate; net income ~$664 million, 2026 revenue (analyst consensus) ~$20.2 billion; 2026 EPS ~$8.42, 2027 ~$9.88.
The bottom line: HELE vs HON
HELE and HON are related but distinct: same themes, different businesses and risks. Neither wins in the abstract, and whichever you pick is worth sizing so one theme does not take over your portfolio. Walnut can show your combined HELE and HON exposure against your real portfolio. It is not an investment adviser.
Wondering how HELE or HON fits the portfolio you already own? Walnut is an AI investing app that connects your brokerage read-only and answers questions like that about your actual holdings: overlap, concentration, and how each position tracks the S&P 500. Compare the best AI portfolio analyzers or see the best AI investing apps in 2026.
Your questions about Helen of Troy Limited
Ask Walnut's AI anything about HELE and see how it fits what you own.
FAQ
What is the difference between HELE and HON?
+
Helen of Troy Limited designs, markets and distributes consumer products across two segments: Home & Outdoor (OXO kitchen and storage tools, Hydro Flask hydration bottles, Osprey packs, PUR filtration) and Beauty & Wellness (Braun and Vicks health devices, Honeywell air treatment, Hot Tools and Drybar hair appliances, Curlsmith). Honeywell, which now operates as Honeywell Technologies (Nasdaq: HON), describes itself as a global, pure-play automation company serving the building, industrial and process sectors through services, solutions and products, run on its Accelerator operating system and its Forge intelligence layer. They show up together because they share investment themes, but they are different businesses, so the better fit depends on which thesis you are expressing.
Is HELE or HON the better stock?
+
Neither is universally better. HON is the larger incumbent; HELE is the smaller challenger and looks cheaper on forward earnings. Walnut is informational, not investment advice. Compare what each does, the tie-breaker metrics above, and the risks, then decide which fits your thesis and what you already own.
Which is cheaper, HELE or HON?
+
On forward P/E (as of November 2026), HELE trades at 8.51x and HON at 21.97x, so HELE is the cheaper of the two on next year's expected earnings. A lower multiple is not automatically the better buy: a richer valuation can be justified by faster growth, and a lower one can reflect real risk. Weigh the multiple against how fast each business is compounding.
Should you own both HELE and HON?
+
Because they share themes, owning both concentrates you in that theme. That can be intentional (a focused bet) or accidental (less diversification than it looks). Walnut can show your combined exposure across both, and whether adding either over-concentrates you, before you buy.
What are the risks of HELE vs HON?
+
HELE: Revenue growth is minimal (~2% year over year in the latest quarter) and Beauty & Wellness sales are still declining, so a sustained rebound is not guaranteed given consumer discretionary softness and competitive private-label pressure. The company carries meaningful debt (~$673 million at the end of fiscal Q2 2027) against little cash, so a downturn in cash flow would raise refinancing and covenant risk. Part of the recent margin and earnings improvement comes from tariff refunds that will not repeat, and future tariff policy could swing the other way. The large goodwill writedown signals that past acquisitions were carried above their current worth. HELE pays no dividend, and after a ~67% gain in 2026 the shares trade near $34.45, above the ~$31.67 average analyst target and below the $37 Empower Brands proposal, so part of the price now rests on a takeover that has no signed agreement behind it; if the bidder withdraws, that support could disappear. The low multiple to sales still reflects genuine uncertainty rather than a guaranteed value opportunity. HON: As a standalone automation company, Honeywell is more exposed to construction activity, manufacturing capex and energy-sector spending than when aerospace aftermarket revenue cushioned results. Earnings are expected to fall sharply in reported terms in 2026 (consensus of about $8.42 of EPS versus far higher prior-year figures that included aerospace), and the separation adds execution risk: stranded costs, new capital structures and a limited standalone reporting history. Debt of about $17.2 billion against about $6.2 billion of cash as of September 2026 leaves the balance sheet a watch point, and Q3 revenue growth of ~1.3% shows how modest organic growth is for now. The productivity solutions (warehouse and barcode) business has shown cyclical softness, and analysts have been trimming price targets (Mizuho cut its target to $255 from $265 in October). Input costs, supply chains and currency swings also affect margins.
Related comparisons
Browse all stock comparisons.
Walnut is informational, not investment advice. This page is descriptive and not a recommendation to buy or sell HELE or HON; figures are approximate and dated (as of November 2026). Verify current data before investing.